Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the
Data de publicación
2012Título da revista
Blood
Tipo de contido
Publicación de congreso